Evidence map›Paper›PMID 40425702›Full record

ArticleScientific reports2025

Structural and biomedical investigations of novel ruthenium schiff base complexes.

Ramadan M Ramadan, Hadeel H El-Shalakany, Mostafa A Sayed

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ramadan M RamadanChemistry Department, Faculty of Science, Ain Shams University, Cairo, 11566, Egypt.
Hadeel H El-ShalakanyChemistry Department, Faculty of Science, Ain Shams University, Cairo, 11566, Egypt.
Mostafa A SayedChemistry Department, Faculty of Science, Ain Shams University, Cairo, 11566, Egypt. mostafa_abdellah@sci.asu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ruthenium(III) complexes with Schiff base ligands bearing diverse functional groups remain extensively underexplored, despite their promising potential in therapeutic applications. To address this gap, we designed and synthesized a new series of mononuclear octahedral Ru(III) complexes with the general formula [RuL

Indexed as

Antineoplastic AgentsCoordination ComplexesRutheniumAnti-Bacterial AgentsCell Line, TumorEscherichia coliHCT116 CellsHumansMCF-7 CellsMolecular Docking SimulationSchiff BasesAnti-Bacterial AgentsAntineoplastic AgentsCoordination ComplexesRutheniumSchiff BasesBiological activityDFT analysisMolecular dockingRu(III) complexesSchiff base ligands

Identifiers

PMID40425702
PMCPMC12117082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.